Earnings Surpass Estimates: Nordson and Zoom Video Lead, Rubicon Technologies Beats Loss Expectations, Kaspien Holdings to Delist Stock
- May 22nd, 2023
- 684 views
Nordson Corporation (Nasdaq: NDSN) has released its second quarter fiscal 2023 earnings per share (EPS) of $2.26, surpassing the consensus estimate of $2.11. The company is maintaining its previously issued guidance for full-year revenue growth, expecting a range of 0% to 3% over the record fiscal year 2022. Additionally, Nordson has narrowed its adjusted earnings guidance to the range of $8.90 to $9.30.
In the after-hours trading session, $NDSN is currently trading at $221.40, showing an increase of $5.16 or 2.39%.
Rubicon Technologies, Inc. (NYSE: RBT) has reported a loss of $0.05 per share for the first quarter of 2023, which is better than the consensus estimate of a loss of $0.30 per share.
$RBT is currently trading at $0.75 in after-hours, reflecting an increase of $0.07 or 9.71%.
Zoom Video Communications, Inc. (Nasdaq: ZM) has reported its first-quarter fiscal-year 2024 earnings per share at $1.16, exceeding the consensus estimate of $0.99.
$ZM is currently trading at $72.51 in after-hours, demonstrating an increase of $1.10 or 1.54%.
Kaspien Holdings Inc. (Nasdaq: KSPN) has notified The Nasdaq Stock Market LLC of its decision to voluntarily delist its common stock from The Nasdaq Capital Market. The company intends to file a Form 25 with the U.S. Securities and Exchange Commission (SEC) on or about June 1, 2023. Consequently, Kaspien Holdings expects the delisting of its common stock to become effective around June 12, 2023.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026January 13th, 2026Wall Street Eyes Bank of America, Wells Fargo, Citi Ahead of Earnings
January 11th, 2026




Member Login